Enanta Pharmaceuticals (ENTA) EBITDA (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded EBITDA of -$16.05 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$17.68 million a year earlier.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) EBITDA (2012 - 2026) Analysis & Trends
On a TTM basis, Enanta Pharmaceuticals' EBITDA came in at -$53.82 million as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$80.76 million.
- Across earlier fiscal years, EBITDA came in at -$119.36 million in FY2024, -$134.84 million in FY2023, -$120.87 million in FY2022 and -$106.24 million in FY2021.
- Quarterly EBITDA has ranged from -$38.91 million in fiscal Q2 2023 to -$10.02 million in fiscal Q1 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$10.64 million (Q2 2026), -$10.02 million (Q1 2026) and -$17.1 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - | -16.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.05 Mn |
| Mar 31, 2026 | -10.64 Mn |
| Dec 31, 2025 | -10.02 Mn |
| Sep 30, 2025 | -17.10 Mn |
| Jun 30, 2025 | -17.68 Mn |
| Mar 31, 2025 | -23.32 Mn |
| Dec 31, 2024 | -22.65 Mn |
| Sep 30, 2024 | -29.38 Mn |
| Jun 30, 2024 | -23.59 Mn |
| Mar 31, 2024 | -32.15 Mn |
| Dec 31, 2023 | -34.24 Mn |
| Sep 30, 2023 | -30.36 Mn |
| Jun 30, 2023 | -36.06 Mn |
| Mar 31, 2023 | -38.91 Mn |
| Dec 31, 2022 | -29.50 Mn |
| Sep 30, 2022 | -26.39 Mn |
| Jun 30, 2022 | -31.82 Mn |
| Mar 31, 2022 | -33.03 Mn |
| Dec 31, 2021 | -29.63 Mn |
| Sep 30, 2021 | -32.92 Mn |
API Access
Enanta Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();